Literature DB >> 16438679

Role of mycobacterial efflux transporters in drug resistance: an unresolved question.

Edda De Rossi1, José A Aínsa, Giovanna Riccardi.   

Abstract

Two mechanisms are thought to be involved in the natural drug resistance of mycobacteria: the mycobacterial cell wall permeability barrier and active multidrug efflux pumps. Genes encoding drug efflux transporters have been isolated from several mycobacterial species. These proteins transport tetracycline, fluoroquinolones, aminoglycosides and other compounds. Recent reports have suggested that efflux pumps may also be involved in transporting isoniazid, one of the main drugs used to treat tuberculosis. This review highlights recent advances in our understanding of efflux-mediated drug resistance in mycobacteria, including the distribution of efflux systems in these organisms, their substrate profiles and their contribution to drug resistance. The balance between the drug transport into the cell and drug efflux is not yet clearly understood, and further studies are required in mycobacteria.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16438679     DOI: 10.1111/j.1574-6976.2005.00002.x

Source DB:  PubMed          Journal:  FEMS Microbiol Rev        ISSN: 0168-6445            Impact factor:   16.408


  75 in total

1.  Rv1218c, an ABC transporter of Mycobacterium tuberculosis with implications in drug discovery.

Authors:  Meenakshi Balganesh; Sanjana Kuruppath; Nimi Marcel; Sreevalli Sharma; Anju Nair; Umender Sharma
Journal:  Antimicrob Agents Chemother       Date:  2010-10-04       Impact factor: 5.191

2.  Rifampicin reduces susceptibility to ofloxacin in rifampicin-resistant Mycobacterium tuberculosis through efflux.

Authors:  Gail E Louw; Robin M Warren; Nicolaas C Gey van Pittius; Rosalba Leon; Adelina Jimenez; Rogelio Hernandez-Pando; Christopher R E McEvoy; Melanie Grobbelaar; Megan Murray; Paul D van Helden; Thomas C Victor
Journal:  Am J Respir Crit Care Med       Date:  2011-04-21       Impact factor: 21.405

Review 3.  Aminoglycoside antibiotics: structure, functions and effects on in vitro plant culture and genetic transformation protocols.

Authors:  I M G Padilla; L Burgos
Journal:  Plant Cell Rep       Date:  2010-07-20       Impact factor: 4.570

4.  Antimycobacterial activity of five efflux pump inhibitors against Mycobacterium tuberculosis clinical isolates.

Authors:  Guilian Li; Jingrui Zhang; Chao Li; Qian Guo; Yi Jiang; Jianhao Wei; Yan Qiu; Xiuqin Zhao; Li-li Zhao; Jianxin Lu; Kanglin Wan
Journal:  J Antibiot (Tokyo)       Date:  2015-10-14       Impact factor: 2.649

5.  Chemical modification of capuramycins to enhance antibacterial activity.

Authors:  Elena Bogatcheva; Tia Dubuisson; Marina Protopopova; Leo Einck; Carol A Nacy; Venkata M Reddy
Journal:  J Antimicrob Chemother       Date:  2010-12-23       Impact factor: 5.790

6.  LfrR is a repressor that regulates expression of the efflux pump LfrA in Mycobacterium smegmatis.

Authors:  Silvia Buroni; Giulia Manina; Paola Guglierame; Maria Rosalia Pasca; Giovanna Riccardi; Edda De Rossi
Journal:  Antimicrob Agents Chemother       Date:  2006-10-16       Impact factor: 5.191

7.  Efflux pumps of Mycobacterium tuberculosis play a significant role in antituberculosis activity of potential drug candidates.

Authors:  Meenakshi Balganesh; Neela Dinesh; Sreevalli Sharma; Sanjana Kuruppath; Anju V Nair; Umender Sharma
Journal:  Antimicrob Agents Chemother       Date:  2012-02-06       Impact factor: 5.191

Review 8.  A balancing act: efflux/influx in mycobacterial drug resistance.

Authors:  G E Louw; R M Warren; N C Gey van Pittius; C R E McEvoy; P D Van Helden; T C Victor
Journal:  Antimicrob Agents Chemother       Date:  2009-05-18       Impact factor: 5.191

9.  Sequence analyses of just four genes to detect extensively drug-resistant Mycobacterium tuberculosis strains in multidrug-resistant tuberculosis patients undergoing treatment.

Authors:  Silke Feuerriegel; Helen S Cox; Nana Zarkua; Hamraev A Karimovich; Kai Braker; Sabine Rüsch-Gerdes; Stefan Niemann
Journal:  Antimicrob Agents Chemother       Date:  2009-05-26       Impact factor: 5.191

10.  Identification of a novel multidrug efflux pump of Mycobacterium tuberculosis.

Authors:  Olga Danilchanka; Claudia Mailaender; Michael Niederweis
Journal:  Antimicrob Agents Chemother       Date:  2008-05-05       Impact factor: 5.191

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.